(Reuters) – India’s Bharat Biotech said on Saturday that it will supply Covaxin directly to state governments at 600 rupees per dose, while it will supply the vaccine directly to private hospitals at 1,200 rupees per dose.
In a tweet, the company said it will develop, manufacture and supply Covaxin to India’s central government at 150 rupees per dose. https://bit.ly/2S1W3zC
The company added that more than 50% of its vaccine capacities have been reserved for supply to the central government.
(Reporting by Juby Babu in Bengaluru; Editing by Marguerita Choy)
